HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,934,568 | +28.9% | 180,954 | +14.6% | 1.36% | +28.9% |
| Q2 2023 | $16,239,501 | -2.3% | 157,895 | +3.7% | 1.06% | +6.3% |
| Q1 2023 | $16,625,187 | +81.0% | 152,329 | +88.7% | 1.00% | +108.6% |
| Q4 2022 | $9,187,415 | +1465.1% | 80,733 | +750.9% | 0.48% | +2171.4% |
| Q3 2022 | $587,000 | -62.8% | 9,488 | -52.1% | 0.02% | -53.3% |
| Q2 2022 | $1,579,000 | +137.8% | 19,793 | +213.4% | 0.04% | +136.8% |
| Q1 2022 | $664,000 | -44.8% | 6,315 | -42.5% | 0.02% | -38.7% |
| Q3 2021 | $1,203,000 | +65.0% | 10,982 | +41.1% | 0.03% | +40.9% |
| Q2 2021 | $729,000 | +222.6% | 7,784 | +216.4% | 0.02% | +266.7% |
| Q1 2021 | $226,000 | -45.9% | 2,460 | -57.0% | 0.01% | -45.5% |
| Q4 2020 | $418,000 | +31.0% | 5,720 | -46.9% | 0.01% | -47.6% |
| Q1 2020 | $319,000 | +6280.0% | 10,768 | +5752.2% | 0.02% | – |
| Q3 2019 | $5,000 | – | 184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |